AzTrials
AzTrials

Autism Spectrum DisorderNCT02439671

Transition Support Program for Young Adults With Autism Spectrum Disorders

A study testing McGill Transition Support Program in people with Autism Spectrum Disorder, run by McGill University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigates a service delivery model to better support young adults with autism spectrum disorders (ASD) in the transition from school to the community. The effectiveness of the "McGill Transition Support Program", a small-group format intervention (meeting once a week for 2 hours over 10 weeks) focusing… Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
McGill Transition Support Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteCanada
Study dates
May 2012to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • proficient and able to communicate in English
  • between the ages of 18 and 30 years upon entering the study
  • ASD classification according to scores on either or both the Social Communication Questionnaire-Lifetime (SCQ) and the Autism Diagnostic Observation Schedule-2 (ADOS-2, Module 4 revised algorithm)
  • Either or both non-verbal IQ, assessed by Raven's Progressive Matrices, or verbal IQ assessed by Wechsler Abbreviated Scales of Intelligence, verbal subtests, in the normal range

Who cannot join

  • current enrollment in another similar transition support service, that is, a group-format service that has the goals of improving the areas of social interaction and communication, self-determination and advocacy, and working with others skills

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • McGill University

    Montreal, Quebec

Other trials in Canada

About this study

Official title: A Service Delivery Model to Better Support Young Adults With Autism Spectrum Disorders in the Transition From School to the Community

This study investigates a service delivery model to better support young adults with autism spectrum disorders (ASD) in the transition from school to the community. The effectiveness of the "McGill Transition Support Program", a small-group format intervention (meeting once a week for 2 hours over 10 weeks) focusing on communication, self-determination and working with others skills, is measured by multiple pre- and post-program-assessments in a "staggered enrollment trial", a variant of a randomized controlled trial (RCT).

Read the detailed description

The difficulties characterizing Autism Spectrum Disorder (ASD) are often associated with childhood; however, ASD is a lifespan diagnosis that continues to impact opportunities in the community. There is currently a very significant gap in support services for young adults with ASDs that has grave consequences both for individuals and their families in terms of vocational success and social inclusion and for society as a whole in terms of the financial burden of long-term adult care.

Individuals on the higher end of the autism spectrum do not have intellectual disability and possess good language skills. Yet they often show significant difficulty with applying their skills during demanding social interactions, which is detrimental to their ability to form relationships and navigate interactions in the workplace. In the few studies of outcomes of adults with ASD it is reported that fewer than 5% of adults at the highest end of the spectrum were living independently and only 12% were employed viably. This underscores the tremendous need for targeted services for young adults with ASD without intellectual disability.

The McGill Transition Support Program was developed to target participants' self-expressed needs in communication, self-determination and working with others skills, which have been associated with better quality of life. Besides the intake, pre- and post-program measures sessions, the participants, aged 18 - 30 years, take part in ten 2-hour group meetings. The study design has been termed a "staggered enrollment trial", that is participants were randomly assigned to take part in the program in the next available cycle or to the waiting list for a subsequent cycle. Pre- and post-program assessment include social problem solving stories, quality of life and self-determination measures, a communication task and a needs and skills questionnaire.

Being tested
McGill Transition Support Program
Keywords
Transition Support Program for young adults
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • McGill Transition Support ProgramBehavioural

    The McGill Transition Support Program is manual-based, including 15 modules of curriculum, five in each of the following domains of skills:

    • Social communication (e.g. listening, perspective taking)
    • Self-determination (e.g. problem-solving, self-advocacy)
    • Working with others (e.g. knowing your context, teamwork)

    Nine out of the 15 modules are selected for each group according to the common needs endorsed by participants on a needs assessment questionnaire. Each group consists of 4 adults and two facilitators who were graduate students in Speech Language Pathology or Educational Psychology.

    The intervention follows a Self-Determination Learning Model of Instruction (SDLMI) that considers the individual's strengths and needs in the development of personal goals and plans for one's future. A workbook is used to accompany each module with the aim of having the participants practice and generalize the main content messages.

Study groups in NCT02439671
Study groupRoleWhat they receive
Immediate interventionExperimentalParticipant assigned to McGill Transition Support Program in next available session
Receives: Behavioral: McGill Transition Support Program
Waiting List controlNo interventionParticipant assigned to waiting list for one session prior to receiving McGill Transition Support Program in following session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Social problem-solving task (Channon & Crawford, 2010)

    Measured: 4-6 weeks prior to session, 4-6 weeks after session

  2. Change in Arc's Self-Determination Scale (SDS; Wehmeyer & Kelchner, 1995)

    Measured: 4-6 weeks prior to session, 4-6 weeks after session, and 12 month follow-up post-Program

  3. Change in Quality of Life Questionnaire (Shalock & Keith, 1993)

    Measured: 4-6 weeks prior to session, abridged version: 4-6 weeks after session and 12 month follow-up post-Program

Secondary outcomes (5)
  1. Curriculum-specific workbook questions

    Measured: every week for 9 weeks at the end of group intervention meetings

  2. Participant Program Evaluation Survey (Flanagan & Nadig, 2012)

    Questionnaire composed of qualitative (open-ended) questions

    Measured: 4-6 weeks after Program and 12 month follow-up post-Program

  3. Parent Program Evaluation Survey (Flanagan & Nadig, 2012)

    (Questionnaire composed of quantitative (Likert-type) and qualitative (open-ended) questions)

    Measured: 4-6 weeks after Program

  4. Questionnaire on vocational, educational and living situation outcomes

    Measured: 12 month follow-up post-Program

  5. Communication task (Nadig, Vivanti, & Ozonoff, 2009)

    Measured: 4-6 weeks prior to session, 4-6 weeks after session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2015 (estimated)
  2. Study startMay 2012
  3. Primary completionJul 2015
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02439671
Sponsor's protocol ID
Max Bell / McGill x-209094
Status last verified
May 2017
First submitted
4 May 2015
Last updated
9 May 2017
Results posted
No
Data monitoring committee
No

Publications

  • Channon S, Crawford S. Mentalising and social problem-solving after brain injury. Neuropsychol Rehabil. 2010 Oct;20(5):739-59. doi: 10.1080/09602011003794583. Epub 2010 Jun 1.

    PubMed 20526955
  • Ganz ML. The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med. 2007 Apr;161(4):343-9. doi: 10.1001/archpedi.161.4.343.

    PubMed 17404130
  • Mercer SL, DeVinney BJ, Fine LJ, Green LW, Dougherty D. Study designs for effectiveness and translation research :identifying trade-offs. Am J Prev Med. 2007 Aug;33(2):139-154. doi: 10.1016/j.amepre.2007.04.005.

    PubMed 17673103
  • Nadig A, Vivanti G, Ozonoff S. Adaptation of object descriptions to a partner under increasing communicative demands: a comparison of children with and without autism. Autism Res. 2009 Dec;2(6):334-47. doi: 10.1002/aur.102.

    PubMed 19998354
  • Taylor JL, Seltzer MM. Changes in the autism behavioral phenotype during the transition to adulthood. J Autism Dev Disord. 2010 Dec;40(12):1431-46. doi: 10.1007/s10803-010-1005-z.

    PubMed 20361245
  • Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry. 2004 Feb;45(2):212-29. doi: 10.1111/j.1469-7610.2004.00215.x.

    PubMed 14982237
  • Barnard J, Harvey V, Potter D, Prior A. Ignored or ineligible? The reality for adults with autism spectrum disorders. The National Autistic Society report for Autism Awareness Week. 2001. London: NAS publications.

  • Flangan T, Nadig A. Transition Support Needs Assessment. 2012

  • Graetz JE. Autism grows up: opportunities for adults with autism. Disability and Society. 2010;25(1):33-47.

  • Hendricks DR, Wehman P. Transition from school to adulthood for youth with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities. 2009;24(2):77-88.

  • Levy A, Perry A. Outcomes in adolescents and adults with autism: A review of the literature. Research in Autism Spectrum Disorders. 2011;5(4):1271-1282.

  • Lord C, Rutter M, DiLavore PC, Risi S. Autism Diagnostic Observation Schedule (ADOS). 1999. Los Angeles, CA: Western Psychological Association.

  • Raven J, Raven JC, Court JH. Manual for Raven's Progressive Matrices and Vocabulary Scales. 2003, updated 2004. San Antonio, TX: Pearson Assessment.

  • Rutter M, Bailey A, Berument SK, Lord C, Pickles A. Social Communication Questionnaire (SCQ). 2003. Los Angeles, CA: Western Psychological Services.

  • Schalock R, Keith K. Quality of Life Questionnaire. 1993, 2004 Revision. Worthington, OH: IDS Publishing.

Questions about this trial

What is this clinical trial studying?

A study testing McGill Transition Support Program in people with Autism Spectrum Disorder, run by McGill University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Social problem-solving task (Channon & Crawford, 2010) (time frame: 4-6 weeks prior to session, 4-6 weeks after session). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02439671, which also lists 20 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2017; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in